Hsing-pang P. Hsieh

Miaoli, TNQ 35040, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Asymmetric Total Synthesis of C2-OH Lycopodium Alkaloids (-)-Palhinine B, (-)-Palhinine C, and (+)-Palhinine B Enabled by Stereocontrolled Diels-Alder Strategy.

Asymmetric Total Synthesis of C2-OH Lycopodium Alkaloids (-)-Palhinine B, (-)-Palhinine C, and (+)-Palhinine B Enabled by Stereocontrolled Diels-Alder Strategy.

Journal: Organic letters

Published: June 15, 2026

Isorhoifolin regulates S1PR3-CK2-GSK3β axis and promotes neurite regrowth and functional recovery after traumatic brain injury.

Isorhoifolin regulates S1PR3-CK2-GSK3β axis and promotes neurite regrowth and functional recovery after traumatic brain injury.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 22, 2026

Noncovalent Interaction Effects on the Acyl Radical Reaction of Bicyclo[2.2.2]octanone: Selective Formation of Rearrangement and Cyclization Products.

Noncovalent Interaction Effects on the Acyl Radical Reaction of Bicyclo[2.2.2]octanone: Selective Formation of Rearrangement and Cyclization Products.

Journal: Organic letters

Published: July 25, 2025

Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix.

Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix.

Journal: Journal of medicinal chemistry

Published: May 20, 2025

Integrating machine learning and protein-ligand interaction profiling for the discovery of METTL3 inhibitors.

Integrating machine learning and protein-ligand interaction profiling for the discovery of METTL3 inhibitors.

Journal: Scientific reports

Published: April 17, 2025

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Journal: Journal of biomedical science

Published: February 19, 2025

Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening.

Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 05, 2024

Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors.

Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors.

Journal: PloS one

Published: November 13, 2024

DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration.

DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration.

Journal: Journal of medicinal chemistry

Published: October 30, 2024

Novel Naphthyridones Targeting Pannexin 1 for Colitis Management.

Novel Naphthyridones Targeting Pannexin 1 for Colitis Management.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 19, 2024

Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma.

Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma.

Journal: International journal of biological macromolecules

Published: September 16, 2024

Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design.

Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design.

Journal: Bioorganic chemistry

Published: August 27, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026